dc.contributor.author |
Deribe, K. |
|
dc.contributor.author |
Yami, A. |
|
dc.contributor.author |
Deribew, A. |
|
dc.contributor.author |
Mesfin, N. |
|
dc.contributor.author |
Colebunders, R. |
|
dc.contributor.author |
Van geertruyden, J. P. |
|
dc.contributor.author |
Woldie, M. |
|
dc.contributor.author |
Maja, T. |
|
dc.date.accessioned |
2015-08-27T12:31:56Z |
|
dc.date.available |
2015-08-27T12:31:56Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
2325-9574 |
|
dc.identifier.doi |
http://dx.doi.org/10.1177/2325957413500528 |
|
dc.identifier.other |
ITG-C5A |
|
dc.identifier.other |
DCS |
|
dc.identifier.other |
U-HIVCLI |
|
dc.identifier.other |
DOI |
|
dc.identifier.other |
Abstract |
|
dc.identifier.other |
UPD59 |
|
dc.identifier.other |
NOBIT |
|
dc.identifier.uri |
http://hdl.handle.net/10390/8469 |
|
dc.description.abstract |
Background:Tuberculosis (TB) remains the most common cause of death in people living with HIV/AIDS. The aim of the present study was to identify predictors of mortality in TB-HIV-coinfected patients. Methods:We conducted an unmatched case-control study among a cohort of TB-HIV-coinfected adults who were on antiretroviral therapy (ART). Cases comprised 69 TB-HIV-coinfected patients who died during this period. For each case, we selected 3 (207) TB-HIV-coinfected patients who were alive during the end of the follow-up period. Results:Male sex (odds ratio [OR] = 2.04, 95% confidence interval [CI]: 1.04-4.02), being bedridden at enrollment (OR = 2.84, 95% CI: 1.17-6.89), and cough of more than 2 weeks during initiation of ART (OR = 4.75 95% CI: 2.14-10.56) were the best predictors of mortality among TB-HIV-infected patients. Conclusion:Mortality among TB-HIV-coinfected patients accounted for a considerable number of deaths among the cohort. Patients with cough at ART initiation and with poor functional status should be strictly followed to reduce death. |
en_US |
dc.language |
English |
en_US |
dc.subject |
Viral diseases |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
AIDS |
en_US |
dc.subject |
Co-infections |
en_US |
dc.subject |
Bacterial diseases |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
Mycobacterium tuberculosis |
en_US |
dc.subject |
Epidemiology |
en_US |
dc.subject |
Mortality |
en_US |
dc.subject |
Predictors |
en_US |
dc.subject |
Gender |
en_US |
dc.subject |
Cough |
en_US |
dc.subject |
Causes of death |
en_US |
dc.subject |
Follow-up |
en_US |
dc.subject |
Ethiopia |
en_US |
dc.subject |
Africa, East |
en_US |
dc.title |
Predictors of mortality among tuberculosis-HIV-coinfected persons in Southwest Ethiopia: a case-control study |
en_US |
dc.type |
Article |
en_US |
dc.citation.issue |
3 |
en_US |
dc.citation.jtitle |
Journal of the International Association of Providers of AIDS Care |
en_US |
dc.citation.volume |
14 |
en_US |
dc.citation.pages |
269-273 |
en_US |
dc.identifier.pmid |
http://www.ncbi.nlm.nih.gov/pubmed/23966102 |
|
dc.citation.jabbreviation |
J Int Assoc Provid AIDS Care |
en_US |